Pathobiology of Left Ventricular Dyssynchrony and Resynchronization

Research output: Contribution to journalArticle

Abstract

Left ventricular mechanical dyssynchrony has recently been recognized as a significant contributor to increased morbidity and mortality in some patients with congestive heart failure. Ventricular dyssynchrony compromises global cardiac mechanical efficiency, induces changes in regional hypertrophy and blood flow, and results in local alterations in myocardial protein expression. Cardiac resynchronization therapy has both immediate and long-term beneficial effects on global cardiac function, and has been shown to reduce both morbidity and mortality in heart failure patients. The effects of resynchronization on the tissue-level and molecular consequences of dyssynchrony remain unknown.

Original languageEnglish (US)
Pages (from-to)26-41
Number of pages16
JournalProgress in Cardiovascular Diseases
Volume49
Issue number1
DOIs
StatePublished - Jul 2006

Fingerprint

Heart Failure
Morbidity
Cardiac Resynchronization Therapy
Mortality
Regional Blood Flow
Hypertrophy
Proteins

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Pathobiology of Left Ventricular Dyssynchrony and Resynchronization. / Spragg, David D; Kass, David A.

In: Progress in Cardiovascular Diseases, Vol. 49, No. 1, 07.2006, p. 26-41.

Research output: Contribution to journalArticle

@article{d1ba4372abf84432aca71da4bd3cb3af,
title = "Pathobiology of Left Ventricular Dyssynchrony and Resynchronization",
abstract = "Left ventricular mechanical dyssynchrony has recently been recognized as a significant contributor to increased morbidity and mortality in some patients with congestive heart failure. Ventricular dyssynchrony compromises global cardiac mechanical efficiency, induces changes in regional hypertrophy and blood flow, and results in local alterations in myocardial protein expression. Cardiac resynchronization therapy has both immediate and long-term beneficial effects on global cardiac function, and has been shown to reduce both morbidity and mortality in heart failure patients. The effects of resynchronization on the tissue-level and molecular consequences of dyssynchrony remain unknown.",
author = "Spragg, {David D} and Kass, {David A}",
year = "2006",
month = "7",
doi = "10.1016/j.pcad.2006.05.001",
language = "English (US)",
volume = "49",
pages = "26--41",
journal = "Progress in Cardiovascular Diseases",
issn = "0033-0620",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Pathobiology of Left Ventricular Dyssynchrony and Resynchronization

AU - Spragg, David D

AU - Kass, David A

PY - 2006/7

Y1 - 2006/7

N2 - Left ventricular mechanical dyssynchrony has recently been recognized as a significant contributor to increased morbidity and mortality in some patients with congestive heart failure. Ventricular dyssynchrony compromises global cardiac mechanical efficiency, induces changes in regional hypertrophy and blood flow, and results in local alterations in myocardial protein expression. Cardiac resynchronization therapy has both immediate and long-term beneficial effects on global cardiac function, and has been shown to reduce both morbidity and mortality in heart failure patients. The effects of resynchronization on the tissue-level and molecular consequences of dyssynchrony remain unknown.

AB - Left ventricular mechanical dyssynchrony has recently been recognized as a significant contributor to increased morbidity and mortality in some patients with congestive heart failure. Ventricular dyssynchrony compromises global cardiac mechanical efficiency, induces changes in regional hypertrophy and blood flow, and results in local alterations in myocardial protein expression. Cardiac resynchronization therapy has both immediate and long-term beneficial effects on global cardiac function, and has been shown to reduce both morbidity and mortality in heart failure patients. The effects of resynchronization on the tissue-level and molecular consequences of dyssynchrony remain unknown.

UR - http://www.scopus.com/inward/record.url?scp=33746048385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746048385&partnerID=8YFLogxK

U2 - 10.1016/j.pcad.2006.05.001

DO - 10.1016/j.pcad.2006.05.001

M3 - Article

C2 - 16867848

AN - SCOPUS:33746048385

VL - 49

SP - 26

EP - 41

JO - Progress in Cardiovascular Diseases

JF - Progress in Cardiovascular Diseases

SN - 0033-0620

IS - 1

ER -